Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genetic Structure Determined for Pathogenic Spirochete

By LabMedica International staff writers
Posted on 27 Oct 2010
The complete genetic structures of 13 strains of the bacteria that cause Lyme disease have been resolved. More...


Lyme disease is the most frequent tick-borne disease in North America and Europe. There are multiple variants of Borrelia burgdorferi, the causative agent, but questions remain about how their variation correlates with different clinical manifestations.

A single genome sequence is not sufficient to understand the relationship between genotypic and geographic variation and disease phenotype. In a collaborative study carried out at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School, (UMDNJ; Newark, NJ, USA), the whole genome sequence of 13 different isolates that span the range of natural variation has been determined. The strains were isolated from human and other natural sources.

New insights into Lyme disease are needed. While the bacterium that causes the disease has been known for 27 years, there still is no vaccine for humans available. The authors believe that their sequence information will help investigators design improved diagnostic tests and vaccines. Efficient tests are needed because the telltale rash on the skin does not always appear in infected patients. Cultures, which work well for many other bacteria, take too long to be of immediate use for Lyme bacteria. Serological and DNA assays have proven to be unsatisfactory. Therefore, these sequences should allow improved understanding of pathogenesis and provide a foundation for novel detection, diagnosis, and prevention strategies.

These new discoveries may accelerate research efforts to diagnose, prevent, and treat the disease, which can affect the nervous system, heart, skin, and joints. The occurrence of the disease has grown dramatically over the past ten years in the U.S. and Europe. There were nearly 30,000 new cases of Lyme disease reported in the U.S. in 2009, and cases have increased by 90% in the U.K.

Steven E. Schutzer, M.D., the senior author of the study, said, "A driving force for doing this project was the observation that certain forms of the bacteria can be more invasive than others. We wanted to find out why and how to identify this property".

The study was published in October 2010 in the Journal of Bacteriology.

Related Links:

University of Medicine and Dentistry of New Jersey





Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.